Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
出版年份 2014 全文链接
标题
Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume 40, Issue 6, Pages 1385-1403
出版商
Oxford University Press (OUP)
发表日期
2014-03-18
DOI
10.1093/schbul/sbu030
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
- (2013) L. Fredrik Jarskog et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight
- (2013) Chun-Hsin Chen et al. JOURNAL OF CLINICAL PSYCHIATRY
- The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
- (2013) Ahmad Ghanizadeh et al. SCHIZOPHRENIA RESEARCH
- No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia
- (2013) Jie Li et al. SCHIZOPHRENIA RESEARCH
- Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia
- (2012) X. Fan et al. ACTA PSYCHIATRICA SCANDINAVICA
- Metformin for Treatment of Antipsychotic-Induced Amenorrhea and Weight Gain in Women With First-Episode Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
- (2012) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Metformin for treatment of antipsychotic-induced weight gain: A randomized, placebo-controlled study
- (2012) Man Wang et al. SCHIZOPHRENIA RESEARCH
- Pro12Ala polymorphism of the PPAR-γ2 gene, metabolic syndrome and response to metformin in clozapine-treated patients
- (2012) Erika Fernández et al. SCHIZOPHRENIA RESEARCH
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial
- (2010) W. Wolfgang Fleischhacker et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: A double-blind, placebo-controlled trial
- (2010) Preeta Kaur Narula et al. SCHIZOPHRENIA RESEARCH
- Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin
- (2010) Erika Fernández et al. SCHIZOPHRENIA RESEARCH
- Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study
- (2010) Lauren C. Bresee et al. SCHIZOPHRENIA RESEARCH
- A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia
- (2009) D. C. Henderson et al. ACTA PSYCHIATRICA SCANDINAVICA
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2009) Grigori Joffe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comorbid Somatic Illnesses in Patients With Severe Mental Disorders
- (2009) W. Wolfgang Fleishhacker et al. JOURNAL OF CLINICAL PSYCHIATRY
- Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients
- (2009) David C. Henderson et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial
- (2009) T. Baptista et al. PHARMACOPSYCHIATRY
- Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
- (2009) Edgardo Carrizo et al. SCHIZOPHRENIA RESEARCH
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
- (2008) Ren-Rong Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study
- (2008) Trino Baptista et al. PSYCHIATRY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now